A study revealed elevated FOXM1 levels in CRC cells, and a reduced decrease in the expression of FOXM1 was associated with enhanced sensitivity to 5‐FU in CRC cells resistant to treatment.120. Here, FOXM1 is linked to colorectal carcinoma.